NCT01330199View on ClinicalTrials.gov

Pharmacokinetics of Tenofovir, Emtricitabine, Maraviroc, and Raltegravir in Cervical, Vaginal, and Rectal Tissues and Secretions

PHASE1CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Healthy Adult Females
Interventions
OTHER

Pharmacokinetic Sampling

Blood plasma, Rectal, Cervical, and Vaginal Tissues and Secretions

Trial Locations (1)

27514

UNC Hospitals CTRC, Chapel Hill

All Listed Sponsors
lead

University of North Carolina, Chapel Hill

OTHER

NCT01330199 - Pharmacokinetics of Tenofovir, Emtricitabine, Maraviroc, and Raltegravir in Cervical, Vaginal, and Rectal Tissues and Secretions | Biotech Hunter | Biotech Hunter